GSK has upgraded its longstanding alliance ... that it has signed a non-binding memorandum of understanding with South Africa-based Afrigen Biologics to support the development of an mRNA vaccine ...
GlaxoSmithKline has spent 20 years trying ... The trial was conducted in three countries where TB is endemic – Kenya, South Africa and Zambia – and involved 3,573 HIV-negative adults between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback